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Conclusion: Above results suggests that contamination of hos-
pital environment due to breaks in transmission control is actually
associated with nosocomial Clostridium difﬁcile infections, the
chances of these infections being directly related with either the
time spent in hospital or with ICU setting.
http://dx.doi.org/10.1016/j.ijid.2014.03.901
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Background: Rickettsioses are zoonotic diseases of global
impact; pathogens include spotted fever (SF), murine typhus (MT)
and scrub typhus (ST). Sennetsu neorickettsiosis (SN) was ﬁrst
reported in Japan but limited information is available on its geo-
graphic distribution and prevalence. We describe characteristics of
serologically-conﬁrmed rickettsioses and SN among febrile illness
patients in Thailand.
Methods & Materials: We prospectively enrolled patients aged
≥7 yearswith undifferentiated febrile illness presenting to the out-
patient and inpatient departments in 4 district hospitals in rural
Thailand during 2002-2005. Serum was collected at enrollment
and from 91% of participants 3-5 weeks later. Antibody titers to SF,
MT, ST and SN were measured by immunoﬂuorescent assay (IFA).
Seropositivitywas deﬁned as immunoglobulin (Ig) G≥1:128 or IgM
≥1:64. Cases of acute infectionwere conﬁrmed by a 4-fold increase
in IgG or IgM titers between acute and convalescent sera.
Results: Of 1,292 patients, 13 (1.0%), 66 (5.1%), 65 (5.1%) and 4
(0.3%) had at least one serum specimen positive for SF, MT, ST and
SN respectively. Acute infection with SF was conﬁrmed in 8 (0.6%),
MT in 24 (1.9%), ST in 23 (1.8%) and SN in 2 (0.2%), respectively. SF
patients (n=8) were less likely than other febrile patients to report
having toilet in their home (63% vs. 99%, P<0.01) or trash removal
in their village (38% vs. 73%, p=0.04).MT patients (n=24)weremore
likely than other febrile patients to present with myalgia (96% vs.
76%, p=0.02) and report seeing rodents around their houses (63%
vs. 23%, p<0.01). Compared to other febrile patients, ST patients
(n=23) were more likely to present with rash (30% vs. 11%, p=0.01),
elevatedaspartate transaminase (91%vs. 51%, p<0.01), andelevated
alanine transaminase (70% vs. 29%, p<0.01). ST patients were more
likely to report insect bites (52% vs. 22%, p<0.01) and cutting down
trees (35% vs. 16%, P=0.04). SN was conﬁrmed in 2 patients, who
both presented with myalgia, fatigue, cough and chest pain.
Conclusion: Spotted fever rickettsioses and sennetsu neorick-
ettsiosis may be under-diagnosed as causes of febrile illness in
Thailand. Further investigation of zoonotic reservoirs is required
to determine risks for infection.
http://dx.doi.org/10.1016/j.ijid.2014.03.902
Type: Poster Presentation
Final Abstract Number: 51.035
Session: Emerging Infectious Diseases
Date: Friday, April 4, 2014
Time: 12:45-14:15
Room: Ballroom
Sero-epidemiological ﬁndings of zoonotic
infections in Maputo suburban residents
B. Lesko1,∗, E. Samo Gudo2, S. Vene3, S.I.
Candido2, N. De Deus4, F. Pinto2, G. Pinto2, I.
Manhica5, K.I. Falk6
1 Karolinska Institutet, Stockholm, Sweden,
Stockholm, Sweden
2 National Institute of Health, Ministry of Health,
Maputo, Mozambique
3 The Public Health Agency of Sweden, Solna, Sweden
4 Instituto Nacional de Saúde, Mozambique, Maputo,
Mozambique
5 National Directorate for Public Health, Ministry of
Health, Maputo, Mozambique
6 MTC, Karolinska Institutet,Stockholm, Solna,
Sweden
Background: In several low-income countries in Africa, e.g.
Mozambique, especially viral zoonotic disease patterns are not
yet well surveyed. Sero-epidemiological studies of relevant human
illnesses will give background data on the spread of diseases in
the population and an indication on prevention and intervention
needed.
Methods & Materials: Thirty febrile patients enrolled in a
study at the Polana Canic¸o Health Center in the suburban areas of
Maputocity,Mozambique, July-September2012were investigated.
Serum/plasmawas analyzed for IgG response to chikungunya virus
(CHIKV), dengue virus (DENV), hantavirus, Rift Valley fever virus
(RVFV), West Nile virus (WNV), and C. burnetii and Brucella sp. All
patients were routinely screened for malaria.
Results: Ten of the 30 patient samples showed positive sero-
epidemiological ﬁnding for ﬂavivirus. 9 out of 10 IgG positive
patients had an unclear diagnosis before the additional study-
analysis was done. 8 patients were IgG-positive for CHIKV,
1 for RVFV, 3 were positive for DENV and 3 for WNV, of
which 2 for both DENV and WNV. All other zoonotic dis-
eases investigated so far were negative. 27% of the 30 patients
had malaria, among those one patient positive for CHIKV.
Results for 60 additional patients (paired acute and convalescent
samples) are pending, but will be presented at the confer-
ence.
Conclusion: Antibodies to CHIKV were found in 27% of the
samples. Interestingly, especially in view of previous report from
Mozambique from the 1980s*, one patient was positive for IgG
antibodies to RVFV. The samples positive for both DENV and
WNV could represent previous infections with the viruses or co-
reactivity. The overall study results indicate passed exposure to
vector borneﬂaviviruses inMaputopatients seekingmedical atten-
tion for fever, and points at widened alternative diagnoses when
investigating patients with febrile illness in the southern African
suburban setting. In particular CHIKV and RVFV could be a pos-
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sible cause of fever or seen as a co-infection to malaria. The
ﬁndings further strengthen the importance of vector control meas-
ures.
The collected material will be further analysed. Neutralization
test might be a way forward, as looking at IgM-reactivity and for
the microbes by PCR.
*Niklasson; Epidem. Inf. (1987), 99, 517-522
http://dx.doi.org/10.1016/j.ijid.2014.03.903
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Investing in emerging infectious diseases: A
systematic analysis of UK research
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Background: Emerging and infectious diseases threaten health,
security, and the global economy. However, little is known about
investments in research to tackle outbreaks and innovate new tools
for infectious disease control.
Methods & Materials: We systematically searched databases
and websites for information on research investments for the
period 1997-2010. We identiﬁed 325,922 studies for screening,
included 6,165 studies in the initial analysis, and identiﬁed 654
studies on emerging infectious diseases in the ﬁnal analysis.
Results: We identiﬁed a total research investment in emerg-
ing infectious diseases of £199 million, accounting for 7.7% of a
total research investment in infectious diseases of £2.6 billion. In
comparison, investment in HIV research amounted to £478million
(18.4% of total investment).
Diagnostic tools for control accounted for £9.8 million (4.9%)
across 66 studies. Studies assessing therapeutics accounted for
£20.0 million (9.9%) across 35 studies. Vaccine research attracted
the least funding for tools to tackle emerging infectious diseases,
with £11.5 million (5.8%) across 24 studies.
Hepatitis C received the most investment with £59.7
million (30.0%), followed by prion research with £33.5 mil-
lion (16.8%),Campylobacter jejuniwith £24.1 million (12.1%),
andHelicobacter pyloriwith £15.1 million (7.6%). Although total
inﬂuenza investment was £80.1 million, funding speciﬁcally for
H5N1 inﬂuenza virus was £13.7 million (6.9%) and for H1N1
inﬂuenza virus was £10.8 million (5.4%).
Public funding accounted for £144.0 million (72.3%) across
361 studies with philanthropic funding awarding £40.6 million
(20.4%) across 173. Preclinical research attracted the most invest-
ment with £142.4 million (71.5%) followed by epidemiological and
operational researchwith £42.1million (21.2%) and product devel-
opment research with £12.2 million (6.1%). Phase 1, 2, 3 clinical
trials was the least well-funded type of research with £2.5 million
(1.2%).
Conclusion: Emerging infectious diseases receives small
amounts of funding compared to other scientiﬁc disciplines, with
the exception of HIV. It is essential that we map, monitor and
evaluate emerging infectious disease research funding given their
importance to global health security.
http://dx.doi.org/10.1016/j.ijid.2014.03.904
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Neurological aspects of human parvovirus B19
infection: A systematic analysis
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Background: Parvovirus B19 has been linkedwith various clini-
cal syndromes including neurological manifestations. However, its
role in the latter remains not completely understood. Although, the
last 10 years witnessed a surge of case reports on B19-associated
neurological aspects, the literature data remains scattered and het-
erogeneous, and epidemiological information on the incidence of
B19-associated neurological aspects cannot be accurately extrapo-
lated. Our aim was to systematically identify the characteristics of
cases of B19-associated neurological manifestations.
Methods & Materials: A computerized systematic review of
existing literature concerning cases of B19-related neurological
aspects was conducted using all databases included in Web of
Knowledge and PubMed database following PRISMA guidelines.
Data were summarized using percentages and cross tabulations.
The 95% conﬁdence intervals for percentageswere calculated using
the Wilson method. All statistical analyses used the conventional
two-sided 5% signiﬁcance level and were carried out using SPSS
version 20 and CIA version 2.0.
Results: As shown in Figure 1, 89 articles describing 129 cases
of B19-related neurological aspects were considered eligible and
further analysed; 79 (61·2%) were associated with central nervous
system manifestations, 41 (31·8%) were associated with peripheral
nervous system manifestations and nine (7·0%) were linked with
myalgic encephalomyelitis. The majority of the cases (50/129) had
encephalitis. Clinical characteristic features of the cases were ana-
lysed, and possible pathological mechanisms were also described.
Conclusion: B19 should be included in differential diagnosis of
encephalitic syndrome of unknown aetiology in all age groups. In
addition, B19 should be included in differential diagnosis of some
peripheral nervous system manifestations such as neuralgic amy-
otrophy. Diagnosis should rely on investigation of anti-B19 IgM
antibodies and B19 DNA in serum or CSF. Treatment of severe cases
couldbeneﬁt fromacombined regimeof intravenous immunoglob-
ulins and steroids.
To conﬁrm these outcomes, goal-targeted studies are recom-
mended to exactly identify epidemiological scenarios and explore
potential pathogenic mechanisms of these complications. Per-
forming retrospective and prospective, and multicenter studies
concerning B19 and neurological aspects are in demand.
http://dx.doi.org/10.1016/j.ijid.2014.03.905
